The Next Chapter for RefinedScience

Drug and diagnostic developers rely on data to guide every major decision, and the industry has generated an enormous volume of biological and clinical data. However, much of that data fails to capture the biology at a resolution sufficient to know what is actually driving human disease. RefinedScience is solving this problem by using primary human tissue, longitudinal clinical data, single-cell analysis, and functional validation to put the best possible disease data in the hands of translational leads and decision makers.

Read the full article on our Substack or download the full PDF with original images and formatting: RS_Next-Chapter_28Oct2026.